Literature DB >> 28004235

Hypopituitarism-needs modern individualized treatment.

Daniel S Olsson1, Bengt-Åke Bengtsson2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 28004235     DOI： 10.1007/s12020-016-1211-3

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  19 in total

Review 1.  The diagnosis of growth hormone deficiency in children and adults.

Authors:  S M Shalet; A Toogood; A Rahim; B M Brennan
Journal:  Endocr Rev       Date:  1998-04       Impact factor: 19.871

2.  Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.

Authors:  G Johannsson; A G Nilsson; R Bergthorsdottir; P Burman; P Dahlqvist; B Ekman; B E Engström; T Olsson; O Ragnarsson; M Ryberg; J Wahlberg; B M K Biller; J P Monson; P M Stewart; H Lennernäs; S Skrtic
Journal:  J Clin Endocrinol Metab       Date:  2011-11-23       Impact factor: 5.958

3.  Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism.

Authors:  Oskar Ragnarsson; Helena Filipsson Nyström; Gudmundur Johannsson
Journal:  Clin Endocrinol (Oxf)       Date:  2012-02       Impact factor: 3.478

Review 4.  Mortality in adults with hypopituitarism: a systematic review and meta-analysis.

Authors:  Sina Jasim; Fares Alahdab; Ahmed T Ahmed; Shrikant Tamhane; Larry J Prokop; Todd B Nippoldt; M Hassan Murad
Journal:  Endocrine       Date:  2016-11-05       Impact factor: 3.633

5.  Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma.

Authors:  Thomas Zueger; Paul Kirchner; Coline Herren; Stefan Fischli; Marcel Zwahlen; Emanuel Christ; Christoph Stettler
Journal:  J Clin Endocrinol Metab       Date:  2012-08-07       Impact factor: 5.958

6.  Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden.

Authors:  Daniel S Olsson; Eva Andersson; Ing-Liss Bryngelsson; Anna G Nilsson; Gudmundur Johannsson
Journal:  J Clin Endocrinol Metab       Date:  2014-11-06       Impact factor: 5.958

7.  Short- and long-term mortality in a prevalent cohort of morbidly obese patients in Italy.

Authors:  Amelia Brunani; Domenico Palli; Simonetta Salvini; Giovanna Masala; Luciana Vallone; Eros Barantani; Antonio Liuzzi
Journal:  Eur J Nutr       Date:  2002-08       Impact factor: 5.614

8.  Premature mortality due to cardiovascular disease in hypopituitarism.

Authors:  T Rosén; B A Bengtsson
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

Review 9.  Long-term effects of recombinant human GH replacement in adults with GH deficiency: a systematic review.

Authors:  Natasha M Appelman-Dijkstra; Kim M J A Claessen; Ferdinand Roelfsema; Alberto M Pereira; Nienke R Biermasz
Journal:  Eur J Endocrinol       Date:  2013-05-28       Impact factor: 6.664

10.  Time trends of mortality in patients with non-functioning pituitary adenoma: a Swedish nationwide study.

Authors:  Daniel S Olsson; Ing-Liss Bryngelsson; Oskar Ragnarsson
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107
View more
  3 in total

1.  Cyclin A in nonfunctioning pituitary adenomas.

Authors:  Elisa B Lamback; Alexandro Guterres; Monique Alvares Barbosa; Carlos Henrique de Azeredo Lima; Debora Aparecida Silva; Aline Helen da Silva Camacho; Leila Chimelli; Leandro Kasuki; Mônica R Gadelha
Journal:  Endocrine       Date:  2020-07-03       Impact factor: 3.633

2.  Impaired neuropsychological functioning in patients with hypopituitarism.

Authors:  Tessa N A Slagboom; Jan Berend Deijen; Christa C Van Bunderen; Hans A Knoop; Madeleine L Drent
Journal:  Endocrinol Diabetes Metab       Date:  2020-06-29

3.  Psychological well-being and illness perceptions in patients with hypopituitarism.

Authors:  Tessa N A Slagboom; Jan Berend Deijen; Christa C Van Bunderen; Hans A Knoop; Madeleine L Drent
Journal:  Pituitary       Date:  2021-02-19       Impact factor: 4.107
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.